BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/80/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 18:55:01 28/06/2024 BST | ||
| 0.093 EUR | +3.33% |
|
| Current month | -61.25% | ||
| 1 month | -57.53% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 0.093 | +3.33% |
| 27/06/24 | 0.09 | -20.35% |
| 26/06/24 | 0.113 | -13.74% |
| 25/06/24 | 0.131 | +7.38% |
| 24/06/24 | 0.122 | -14.69% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 06:55 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM9PRQ |
| ISIN | DE000VM9PRQ7 |
| Date issued | 02/02/2024 |
| Strike | 80 $ |
| Maturity | 20/09/2024 (82 Days) |
| Parity | 10 : 1 |
| Emission price | 0.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.49 € |
|---|---|
| Lowest since issue | 0.09 € |
| Spread | 0.01 € |
| Spread % | 8.77% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
92.37
USD
Average target price
96.05
USD
Spread / Average Target
+3.99%
- Stock Market
- Warrants
- Warrant
